Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Smith

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|August 3, 2022
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal ImpairmentJames A Dowell, Thomas C Marbury, William B Smith, et al.
Clinical and Translational Allergy|March 30, 2019
Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance?Sepehr Shakib, Gillian E Caughey, Jie Shen Fok, et al.
The Medical Journal of Australia|November 16, 2004
A2 milk is allergenicWilliam B Smith, Deryn Thompson, Margaret Kummerow, et al.
Journal of Animal Science|July 5, 2023
Forages and pastures symposium: an update on in vitro and in situ experimental techniques for approximation of ruminal fiber degradationJamie L Foster, William B Smith, F Monte Rouquette, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum SessionGary L Steinman, William B Smith, Mary L Westrick, et al.
Cancer Chemotherapy and Pharmacology|May 26, 2020
Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairmentKen Ogasawara, William B Smith, Christine Xu, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Safety in FIH Trials: A Summary of the Symposium "Fatal Drug Trial in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost"Howard E Greenberg, Mattheus Thijs van Iersel, Mary L Westrick, et al.
The Journal of Organic Chemistry|October 9, 2007
Dihalocarbene insertion reactions into C-H bonds of compounds containing small rings: mechanisms and regio- and stereoselectivitiesUdo H Brinker, Guoying Lin, Linxiao Xu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 19, 2011
A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of feverW Frank Peacock, James B Breitmeyer, Christine Pan, et al.
The Laryngoscope|April 5, 2005
Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitisHarshita Pant, Frank E Kette, William B Smith, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|August 3, 2022
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal ImpairmentJames A Dowell, Thomas C Marbury, William B Smith, et al.
Clinical and Translational Allergy|March 30, 2019
Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance?Sepehr Shakib, Gillian E Caughey, Jie Shen Fok, et al.
The Medical Journal of Australia|November 16, 2004
A2 milk is allergenicWilliam B Smith, Deryn Thompson, Margaret Kummerow, et al.
Journal of Animal Science|July 5, 2023
Forages and pastures symposium: an update on in vitro and in situ experimental techniques for approximation of ruminal fiber degradationJamie L Foster, William B Smith, F Monte Rouquette, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum SessionGary L Steinman, William B Smith, Mary L Westrick, et al.
Cancer Chemotherapy and Pharmacology|May 26, 2020
Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairmentKen Ogasawara, William B Smith, Christine Xu, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Safety in FIH Trials: A Summary of the Symposium "Fatal Drug Trial in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost"Howard E Greenberg, Mattheus Thijs van Iersel, Mary L Westrick, et al.
The Journal of Organic Chemistry|October 9, 2007
Dihalocarbene insertion reactions into C-H bonds of compounds containing small rings: mechanisms and regio- and stereoselectivitiesUdo H Brinker, Guoying Lin, Linxiao Xu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 19, 2011
A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of feverW Frank Peacock, James B Breitmeyer, Christine Pan, et al.
The Laryngoscope|April 5, 2005
Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitisHarshita Pant, Frank E Kette, William B Smith, et al.
Pageof 11